Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Takano Co.,Ltd. (7885.T)
Nagano, JP
Takano Co., Ltd., a diversified Japanese company founded in 1941 and based in Nagano, manufactures and distributes a wide array of products across several sectors. Its offerings include office furniture, such as swivel and conference chairs, along with specialized medical and healthcare equipment like stretchers, wheelchairs, cushions, and walking aids. The company also produces exterior items, including awnings, parasols, and multi-utility room solutions. Within the industrial domain, Takano develops electromagnetic electrical components and various spring and unit components, such as precision, wiring, and spiral springs. Furthermore, their expertise extends to advanced inspection and measurement systems, encompassing BodiTrak pressure mapping, as well as systems for LCD panels, battery-related materials, and web inspections. The company additionally provides health foods. Formerly known as Takano Factory Co.,Ltd., the company adopted its current name in 1973.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.50% | -2.42% | -4.55% | +28.21% | +37.98% | +32.58% | +45.83% | +38.16% | +70.73% | +65.35% | -19.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Furnishings, Fixtures & Appliances: +2.7%+3.5% ★ Q1'26: +2.7% (vs Q1'25)
-
EPS growth Furnishings, Fixtures & Appliances: +4.0%+18.4% ★ Q1'26: -0.2% (vs Q1'25)
-
FCF margin FCF growth · Furnishings, Fixtures & Appliances: +24.2%+3.4% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Furnishings, Fixtures & Appliances: +6.9%+3.4% Q1'26: +9.1% (vs Q1'25)
-
ROIC Furnishings, Fixtures & Appliances: +6.4%—
-
Share dilution Furnishings, Fixtures & Appliances: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Furnishings, Fixtures & Appliances: -0.16×— Q1'26: 0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2022 actual |
Mar 2023 actual |
|---|---|---|---|---|---|
| Revenue |
21.90B
est: 22.40B (-2.2%)
|
21.70B
est: 22.40B (-3.1%)
|
23.66B
est: 23.40B (+1.1%)
|
22.75B
est: 22.50B (+1.1%)
|
23.04B
est: 24.00B (-4.0%)
|
| EBITDA |
1.88B
est: 1.71B (+10.0%)
|
1.96B
est: 1.71B (+14.5%)
|
2.26B
est: 1.79B (+26.6%)
|
2.13B
est: 1.72B (+24.0%)
|
2.02B
est: 1.83B (+10.1%)
|
| EBIT |
1.17B
est: 768.70M (+52.5%)
|
1.21B
est: 768.70M (+57.6%)
|
1.33B
est: 803.02M (+65.4%)
|
1.22B
est: 772.13M (+57.4%)
|
1.11B
est: 823.61M (+34.3%)
|
| Net Income |
845.31M
est: 811.31M (+4.2%)
|
885.75M
est: 1.05B (-15.8%)
|
959.06M
est: 1.24B (-22.8%)
|
894.41M
est: 400.33M (+123.4%)
|
828.97M
est: 500.79M (+65.5%)
|
| SGA |
130.49M
est: 3.80B (-96.6%)
|
3.07B
est: 3.80B (-19.3%)
|
3.43B
est: 3.97B (-13.7%)
|
3.64B
est: 3.82B (-4.8%)
|
3.89B
est: 4.07B (-4.5%)
|
| EPS |
55.63
est: 53.30 (+4.4%)
|
58.29
est: 69.10 (-15.6%)
|
63.11
est: 81.60 (-22.7%)
|
58.84
est: 26.30 (+123.7%)
|
54.46
est: 32.90 (+65.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B+ | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 2/5 | 3/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akio Ohara | MD, Director, Head of Corporate Planning Division, HR Department & Agri Business Promotion Office | — | male |
| Masao Takano | President, Chief Executive Officer & Director | — | male |
| Tsutomu Takano | Senior MD, Assistant to the President, Head of TQM Promotion Office & Director | — | male |
| Yasuhiro Ueda | Director & Director of Pharmaceutical Affairs Office & Technical Development Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7885.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
